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prior to and 6 months after undergoing elective PTCA. The MOS-36 includes 
8 individual indices: physical roles (PR), bodily pain (BP), social functioning 
(SF), ,~metional roles (ER), mental health (MH), physical functioning, gen- 
eral health, and vitality. Acute angina, of less than 1 month duration, was 
noted in 42% of the total cohort (Group 1 ). Chmnio angina was noted in 48% 
(Group 2). Demographic and procedure; PTCA resalis were similar in the 2 
groups. Changes in the MOS-36 indices, at baseline and at fo!PJw.up, were 
compared, Group 1 had anly a positive trend in physical roles. However, 
Group 2 had statistically significant increases in physiceJ roles, bodily pain, 
and emotional roles; a positive trend in mental health and social functioning 
was ob:.awed. 
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In conclusion, 1) Differences exist in QOL changes after PTCA between 
patients with acute or chronic angina; 2) PTCA provides a significant positive 
effect on QOL on patients with chronic angina; 3) The quantitative valuation 
of QOL may Ix) an important outcome measurement for the cNaioation of 
therapeutic strategies for patients with chronic angina. 
Early Chronotropic Incompetence Predicts the 
Need for  Atropine During Oobutsmme ba'ess 
Echocerdlography 
Anne M. Hepner, David S. Bach, William F. Armstrong. University of 
Michigan Hospitals, Ann Arbor, MI 
Atropine (AT) has been used at peak dobutamine (OB) infusion dudng dobu- 
tamine stwss echocardiography (DSE) to increase sensitivity in palients (pts) 
with an inadequate heart rate (HR) response to DB. Earlier administration of 
AT may provide a more balance', ~inotropic and chronotropio response and 
petantiS~iy shorten study time. The puq0ose of this stlxly was to determine 
whofher HR at 20 mcg/kg/mio (HR 20) was predi~ive of the need for AT at 
peak DB infusion. HR response dudng DSE (10, 20, 30, 40 mcg/kg/min) was 
retrospectively evaluated at each stage in 132 pts. AT was added at peak 
infusion if the HR was < 100. Pts were divided into two groups based upon 
the need fur AT to achieve a HR > 100. 
Base HR HR 20 HR Peak HR post AT 
AT, n - 66 6~ (40.-g6) 65(48-97) 72(53-86) 102(76-144) 
No AT, n - 64 74 (55-100) 95 (70-126) 120 (100-141)) - 
Pts requiring AT were mere likely to be taking beta blockers (78°/,, versus 
17% (p < 0,001). The groups were otherwise similar in terms of age and 
use of calcium blockers. HR 20 was assessed at different threshold levels in 
terms of appropriate (APPR) or inappropriate (INAPPR) identification (ID) of 
the need fur AT. 
HR20 <05 <70 <75 
APPR ID 40/66 (61%) 47/68 (71%} 57/66(86%) 
INAPPR EO ~/~4 (2%) 2/S4 (3%) S/S4 (8%) 
HR 20 is prsdtctlve of the need for AT in the majority of Pta. Early ad" 
mintslnltion of AT may provide a mere balanced inobopin and chrono~ 
~-~,pOnes in pts who requtro it 8nd shorte~ study time potentially reducing 
adverse side-effecta. In this study If all pta wifh a HR 20 < 70 received eadY 
AT at 20 mcg/19g/mln DB, this would represent 71% of all pta who w.,~:.'d 
mquke AT at pesk. The remaining 20% of AT nKlutdng Pta could v-,:~.~ve it at 
pea~ prespac~5 stodm m requlred to ~he~ evak~ ~ advant~e of 
this tachnlque. 
[ " ~  B .e~-Blocldng Antlanginal Agent Does Not Change 
Pain i nreshold end Bets-Endorphin Level in 
Patients With Silent Myocardial Ischemla 
Bonpei Takase, Akira Kurita, Hiroyuki Hikita, Akimi Ueh~ta, Tomoo Nagai, 
Kimio Safomura, Kazusige isojlma, Hamo Nakamura. N3tional L)efense 
Medical College, S~tarna, Japan 
Pain threshold (PT} and plasma level of p endorphin (END) are involved 
in the pathogenesis of silent myocardial ischemia (SMI), Since p blocking 
agents improve SMI episodes, these agents might influence PT or END 
through reducing myocardial ischemic stimuli. To investigate the effect of p 
blocking agents on PT and END, we measured PT and plasma level of END 
at rest and peak exercise (Ex) of Irsadmill testing (TT) in 32 patients (pts, 
61 • 8 years) with angiographio documented coronary artery disease before 
and after medication. All pts had SMI _> 1 (1 > ram, 1 > min, J 60 me) in 
24 h aml0ulafory ECG monitoring (AECG) and positive TT. Blood samples 
obtained from the antecubitel vein and END (pg/ml) was assayed using 
RIA. PT (mA) was determined by electrical skin stimulation to the forearm. 
CartaQiol (CTL, 15 mg),/~ 1 selective and iSA (+), and niprediiol (NIP, 6 mg), 
non-selective and ISA (-), were given with a single blind, 2-wesk placebo- 
controlled esign and pts were randomly allocated to CTL or NIP treatment 
arm. Results were shown below. 
PT END PT END 
Placebo 1.9/2.4" 10.0114,0" Plac~se 1.7/2.2" 8.3/14.1" 
CTL 1.7/2.1" 9.8/12.8" NiP 1.8/2.3" 7.5/18.4" 
Rest/Ex; figures In table, mean; *p < 0.05 ~ Rest. 
PT and END signir.=antly increased by exercise in exeroise-inducad silent 
myocardial ischemia, and both CTL and NIP i rn~ TT results and SMI 
episodes in AECG. However. either CTL or NIP did not signircantly influence 
PT and END. Cenotus/ons; The measurement of PT and END in pts on 
b.lucking an~dangfna] med'¢a~n still provides useful information to elucidate 
the mechanisms of silent myocardial ischemia. 
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~"6"~ Open I'lea."t Without A Surgery TranMuMon: 
Multimodality Strategy in Over Forty Consecutive 
Jehovah's Witness Patients 
Todd K. Rasengert, Bob Helm, Feminand Velesco, William DeBois, 
S~muel I.P_J~, J6ffmy P. Gold, O. Wayne Isom, Karl H. Kdeger. New York 
HospitaI-ComeU Medical Center. New York, IV. Y. 
Bleeding and blood transfusion remain substantial dsks of open heart surgery 
(OHS), despite multiple iodMdual advances in blood conservation technique. 
We consequently developed an integrated strategy, and prospectively applied 
this program for all 43 Jehovah's Wifnass patients (JW), aged 2-82 years, 
requiting OHS at our institu6on since 1992. Operations performed included 
coronary bypass (CBG) with internal n~nmmy artery (n = 30,1 mop), mitml 
valve mplacament (n = 4, 2 rasps), atrial septet defict repair (n - 4), aortic 
valve r e ~  (n = 3), and CBG/aorticJmilz~ valve replacement, chronic 
type 1 dissection repair, and (pediatric) anffio root reconstnc~n (n = 1 
each). The Intngmted program included: 1) apm1~in (full dese regimen), 2) 
high dose e~thropeiathl (800 U/kg Initial dose, 500 U/I,,o every other day), 
3) maximum volume (co~nuous circuit) InVasperetive autologn,s dar~n 
(target on-bypass hematcodt pet] 18%, mean volume w~dckawa: 1200 =~), 
4) reVognzcfo autologous pump priming, 5) on-bypass hemoconcant~on, 
and 6) smali volume byT.,z,~ circuitry. A subset analysis was performed of 
the 30 JW CBG pts vs 30 CBG pts operated on dudng tho same ti,n~ 
pedod who were evenly matched for established transfusion risk faciom, 
including age, ge,-,d~,-, red cell mass/hct, and ~.~pidn/hepadn use. There was 
no d~emnoa in mortality, stroke, ronel failure, or m ' ~  i:/farotion rata. 
No JW received any blood transfusion, compared wdh 17(57%) contxol pts 
(1.8 :b p_8 expesu~ p < 0,01 ). Chest lobe ~aJnage 24 hr pest-op was 
380 ~ 200 ml vs 1000:1:320 ml (p < 0.001), and hcts were 32:1: 6% vs 28 
:1: 4% at 24 hr (p < 0.001) and34 ±3%ve 30 ± 4% at clay 6 pest-op (p = 
0.02S) io JW and comrof pts, ~ .  The DRG-correcLad past-op ~;gth 
of Stay and ovecall coats were decroased In JW ~ control Pts. Thase msuRs 
sugOasz tlmt an thtegretad comewa~ stretagy can markadly rsduce the 
nesd fur blond Uandus~s In OHS In a safe and ,'ost-effective mannec 
